Zobrazeno 1 - 10
of 1 764
pro vyhledávání: '"Paraneoplastic Syndromes, Nervous System"'
Autor:
Kerstens J; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Schreurs MWJ; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., de Vries JM; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Neuteboom RF; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Brenner J; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Crijnen YS; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., van Steenhoven RW; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., de Bruijn MAAM; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., van Sonderen A; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., van Coevorden-Hameete MH; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Bastiaansen AEM; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Vermeiren MR; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Damoiseaux JGMC; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Otten HG; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Frijns CJM; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Meek B; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Platteel ACM; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., van de Mortel A; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Delnooz CCS; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Broeren MAC; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Verbeek MM; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Hoff EI; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Boukhrissi S; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Franken SC; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Nagtzaam MMP; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Paunovic M; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Veenbergen S; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Sillevis Smitt PAE; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands., Titulaer MJ; From the Department of Neurology (J.K., J.M.V., R.F.N., J.B., Y.C., R.W.v.S., M.A.A.M.d.B., M.H.v.C.-H., A.E.M.B., M.V., S.C.F., M.M.P.N., M.P., P.A.E.S.S., M.J.T.); Department of Immunology (M.S., S.B., S.V.), Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam; Department of Neurology (M.A.A.M.D.B.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.v.S.), Haaglanden Medical Center, The Hague; Central Diagnostic Laboratory (J.D.), Maastricht University Medical Center; Central Diagnostic Laboratory (H.G.O.); Department of Neurology (C.J.M.F.), Utrecht University Medical Center; Department of Medical Microbiology and Immunology (B.M.), Saint Antonius Hospital, Nieuwegein; Laboratory of Medical Microbiology and Immunology (A.C.M.P.), Elisabeth-TweeSteden Hospital, Tilburg; Department of Neurology (A.M., C.C.D.); Clinical Laboratory (M.A.C.B.), Máxima Medical Center, Veldhoven; Departments of Neurology and Human Genetics (M.M.V.), Radboud University Medical Center, Nijmegen; and Department of Neurology (E.I.H.), Zuyderland Medical Center, Heerlen, The Netherlands.
Publikováno v:
Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2024 Nov; Vol. 11 (6), pp. e200318. Date of Electronic Publication: 2024 Oct 28.
Autor:
Ciano-Petersen NL; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Muñiz-Castrillo S; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Villagrán-García M; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Farina A; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Vogrig A; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Wucher V; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Duy L; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Birzu C; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Goncalves D; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Flabeau O; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Duwicquet C; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Benard A; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Nicole F; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Rogemond V; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Picard G; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Joubert B; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France., Honnorat J; From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Hospices Civils de Lyon, Hôpital Neurologique, Bron; MeLiS - UCBL-CNRS UMR 5284 - INSERM U1314 (N.L.C.-P., S.M.-C., M.V.-G., A.F., V.W., L.D.D., V.R., G.P., B.J., J.H.), Université Claude Bernard Lyon 1, France; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND (N.L.C.-P.); Red Andaluza de Investigación Clínica y Traslacional en Neurología (NeuroRECA) (N.L.C.-P.), Málaga, Spain; Center for Sleep Sciences and Medicine (S.M.-C.), Stanford University, Palo Alto, CA; Department of Neuroscience (A.F.), Psychology, Pharmacology and Child Health. University of Florence, Italy; Clinical Neurology (A.V.), Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC); Department of Medicine (DMED) (A.V.), University of Udine, Udine, Italy; Sorbonne Université (C.B.), Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin; OncoNeuroTox Group (C.B.), Center for Patients with Neurological Complications of Oncologic Treatments, GH Pitié-Salpetrière et Hôpital Percy, Paris; Immunology Department (D.G., F.N.), Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Service de Neurologie (O.F.), Centre Hospitalier de la Côte Basque, Bayonne; Department of Neurology (C.D.), University Hospital of Tours; and Service de Neurologie (A.B.), Centre Hospitalo-Universitaire Rennes, France.
Publikováno v:
Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2024 Nov; Vol. 11 (6), pp. e200260. Date of Electronic Publication: 2024 Oct 07.
Autor:
Graus F; Neuroimmunology Program, Institute for Biomedical Research August Pi i Sunyer (IDIBAPS), Casanova, 143, Floor 3rd, 08036 Barcelona, Spain. Electronic address: francesc.graus@idibaps.org.
Publikováno v:
Revue neurologique [Rev Neurol (Paris)] 2024 Nov; Vol. 180 (9), pp. 848-861. Date of Electronic Publication: 2024 Sep 16.
Autor:
Thaler F, Dieterich M
Publikováno v:
Fortschritte der Neurologie-Psychiatrie [Fortschr Neurol Psychiatr] 2024 Oct; Vol. 92 (10), pp. 400-401. Date of Electronic Publication: 2024 Oct 11.
Autor:
Muñiz-Castrillo S; Stanford Center for Sleep Sciences and Medicine, Stanford University, 3165 Porter Drive, Palo Alto, CA, 94304, USA., Villagrán-García M; French Reference Center for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Lyon, France.; MeLiS, UCBL-CNRS UMR 5284, INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France., Peris Sempere V; Stanford Center for Sleep Sciences and Medicine, Stanford University, 3165 Porter Drive, Palo Alto, CA, 94304, USA., Farina A; French Reference Center for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Lyon, France.; MeLiS, UCBL-CNRS UMR 5284, INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France., Pinto AL; French Reference Center for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Lyon, France.; MeLiS, UCBL-CNRS UMR 5284, INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France., Picard G; French Reference Center for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Lyon, France.; MeLiS, UCBL-CNRS UMR 5284, INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France., Rogemond V; French Reference Center for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Lyon, France.; MeLiS, UCBL-CNRS UMR 5284, INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France., Honnorat J; French Reference Center for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Lyon, France.; MeLiS, UCBL-CNRS UMR 5284, INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France., Mignot E; Stanford Center for Sleep Sciences and Medicine, Stanford University, 3165 Porter Drive, Palo Alto, CA, 94304, USA. mignot@stanford.edu.
Publikováno v:
Journal of neurology [J Neurol] 2024 Sep; Vol. 271 (9), pp. 6336-6342. Date of Electronic Publication: 2024 Jul 11.
Autor:
Yang H; Department of Gastroenterology and Hepatology, Beijing You'an Hospital, Capital Medical University, China; Department of Gastroenterology, the Second People's Hospital of Chengdu, China., Chen L; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilian University of Munich, Munich, Germany. Electronic address: chenlimunich@gmail.com.
Publikováno v:
Asian journal of surgery [Asian J Surg] 2024 Sep; Vol. 47 (9), pp. 4184-4185. Date of Electronic Publication: 2024 May 18.
Autor:
Peter E; Inserm U1314/UMR CNRS5284, SynatAc Team, MeLis Institute, Lyon, France; French Reference Center on Paraneoplastic Neurological Syndromes, Hospices Civils de Lyon, Lyon, France; University of Lyon, Université Claude-Bernard Lyon 1, Lyon, France., Dumez P; Inserm U1314/UMR CNRS5284, SynatAc Team, MeLis Institute, Lyon, France; French Reference Center on Paraneoplastic Neurological Syndromes, Hospices Civils de Lyon, Lyon, France; University of Lyon, Université Claude-Bernard Lyon 1, Lyon, France., Honnorat J; Inserm U1314/UMR CNRS5284, SynatAc Team, MeLis Institute, Lyon, France; French Reference Center on Paraneoplastic Neurological Syndromes, Hospices Civils de Lyon, Lyon, France; University of Lyon, Université Claude-Bernard Lyon 1, Lyon, France., Desestret V; Inserm U1314/UMR CNRS5284, SynatAc Team, MeLis Institute, Lyon, France; French Reference Center on Paraneoplastic Neurological Syndromes, Hospices Civils de Lyon, Lyon, France; University of Lyon, Université Claude-Bernard Lyon 1, Lyon, France. Electronic address: virginie.desestret@chu-lyon.fr.
Publikováno v:
Revue neurologique [Rev Neurol (Paris)] 2024 Nov; Vol. 180 (9), pp. 931-939. Date of Electronic Publication: 2024 Sep 19.
Autor:
Zhao-Fleming H; From the Departments of Neurology (H.Z.-F., M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.) and Laboratory Medicine and Pathology (M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.), Mayo Clinic, Rochester, MN; and Department of Neurology (S.S.), Vanderbilt University, Nashville, TN., Rezk M; From the Departments of Neurology (H.Z.-F., M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.) and Laboratory Medicine and Pathology (M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.), Mayo Clinic, Rochester, MN; and Department of Neurology (S.S.), Vanderbilt University, Nashville, TN., Shah S; From the Departments of Neurology (H.Z.-F., M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.) and Laboratory Medicine and Pathology (M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.), Mayo Clinic, Rochester, MN; and Department of Neurology (S.S.), Vanderbilt University, Nashville, TN., Gupta P; From the Departments of Neurology (H.Z.-F., M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.) and Laboratory Medicine and Pathology (M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.), Mayo Clinic, Rochester, MN; and Department of Neurology (S.S.), Vanderbilt University, Nashville, TN., Zekeridou A; From the Departments of Neurology (H.Z.-F., M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.) and Laboratory Medicine and Pathology (M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.), Mayo Clinic, Rochester, MN; and Department of Neurology (S.S.), Vanderbilt University, Nashville, TN., Flanagan EP; From the Departments of Neurology (H.Z.-F., M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.) and Laboratory Medicine and Pathology (M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.), Mayo Clinic, Rochester, MN; and Department of Neurology (S.S.), Vanderbilt University, Nashville, TN., Pittock SJ; From the Departments of Neurology (H.Z.-F., M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.) and Laboratory Medicine and Pathology (M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.), Mayo Clinic, Rochester, MN; and Department of Neurology (S.S.), Vanderbilt University, Nashville, TN., McKeon A; From the Departments of Neurology (H.Z.-F., M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.) and Laboratory Medicine and Pathology (M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.), Mayo Clinic, Rochester, MN; and Department of Neurology (S.S.), Vanderbilt University, Nashville, TN., Dubey D; From the Departments of Neurology (H.Z.-F., M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.) and Laboratory Medicine and Pathology (M.R., P.G., A.Z., E.P.F., S.J.P., A.M., D.D.), Mayo Clinic, Rochester, MN; and Department of Neurology (S.S.), Vanderbilt University, Nashville, TN.
Publikováno v:
Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2024 Dec; Vol. 11 (6), pp. e200316. Date of Electronic Publication: 2024 Sep 25.
Autor:
Zekeridou A
Publikováno v:
Continuum (Minneapolis, Minn.) [Continuum (Minneap Minn)] 2024 Aug 01; Vol. 30 (4), pp. 1021-1051.
Autor:
Saitou A; Department of Respiratory Medicine, Otaru General Hospital, Japan., Shioya M; Department of Respiratory Medicine, Otaru General Hospital, Japan., Nagahisa Y; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Japan., Haseyama A; Department of Respiratory Medicine, Tonan Hospital, Japan., Niwa R; Department of Respiratory Medicine, Otaru General Hospital, Japan., Tsuchimoto J; Department of Respiratory Medicine, Otaru General Hospital, Japan., Chiba H; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Japan.
Publikováno v:
Internal medicine (Tokyo, Japan) [Intern Med] 2024 Jul 15; Vol. 63 (14), pp. 2059-2062. Date of Electronic Publication: 2023 Dec 04.